Abstract

Multiple sclerosis affects more than 2 million people worldwide and is currently incurable. A number of interventions to modify the course of multiple sclerosis have been developed that offer new insight into disease mechanisms.

Keywords

Multiple sclerosisMedicineDiseaseIntensive care medicineNeurosciencePsychologyPathologyImmunology

MeSH Terms

AntibodiesMonoclonalBiomarkersBrainGlatiramer AcetateHumansImmunologic FactorsInterferon-betaMagnetic Resonance ImagingMultiple Sclerosis

Affiliated Institutions

Related Publications

Multiple sclerosis – a review

Ruth Dobson , Gavin Giovannoni

Multiple sclerosis ( MS ) is the commonest non‐traumatic disabling disease to affect young adults. The incidence of MS is increasing worldwide, together with the socioeconomic i...

2018 European Journal of Neurology 1915 citations

Publication Info

Year
2018
Type
review
Volume
378
Issue
2
Pages
169-180
Citations
2248
Access
Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2248
OpenAlex
36
Influential
2093
CrossRef

Cite This

Daniel S. Reich, Claudia F. Lucchinetti, Peter A. Calabresi (2018). Multiple Sclerosis. New England Journal of Medicine , 378 (2) , 169-180. https://doi.org/10.1056/nejmra1401483

Identifiers

DOI
10.1056/nejmra1401483
PMID
29320652
PMCID
PMC6942519

Data Quality

Data completeness: 86%